Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on March 05, 2016, to fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement and Record Date / Book Closure Dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the Company. Further, in view of the above the trading window for of dealing with equity shares of the Company by the Designated Persons has been closed with immediate effect and shall continue to remain closed until March 09, 2016.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internatl. | 436.10 |
| Indegene | 519.10 |
| CMS Info Systems | 291.40 |
| JITF Infralogistics | 315.55 |
| Sagility | 40.36 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: